While West Pharmaceutical Services, Inc. has overperformed by 3.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, WST rose by 21.55%, with highs and lows ranging from $415.73 to $310.42, whereas the simple moving average jumped by 8.75% in the last 200 days.
On February 07, 2024, Jefferies Upgraded West Pharmaceutical Services, Inc. (NYSE: WST) to Buy. A report published by BofA Securities on June 16, 2023, Upgraded its rating to ‘Buy’ for WST. Stephens also Upgraded WST shares as ‘Overweight’, setting a target price of $400 on the company’s shares in a report dated April 11, 2023. Deutsche Bank Initiated an Hold rating on December 14, 2022, and assigned a price target of $250. UBS initiated its ‘Neutral’ rating for WST, as published in its report on November 30, 2022. BofA Securities’s report from October 28, 2022 suggests a price prediction of $250 for WST shares, giving the stock a ‘Neutral’ rating. KeyBanc Capital Markets also rated the stock as ‘Overweight’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of West Pharmaceutical Services, Inc. (WST)
With WST’s current dividend of $0.78 per share, investors can expect to earn a return regardless of performance. Further, the quarter-over-quarter increase in sales is 3.35%, showing a positive trend in the upcoming months.
West Pharmaceutical Services, Inc.’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 21.32% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.24, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and WST has an average volume of 547.75K. On a monthly basis, the volatility of the stock is set at 3.45%, whereas on a weekly basis, it is put at 3.51%, with a gain of 10.28% over the past seven days. Furthermore, long-term investors anticipate a median target price of $397.40, showing decline from the present price of $399.39, which can serve as yet another indication of whether WST is worth investing in or should be passed over.
How Do You Analyze West Pharmaceutical Services, Inc. Shares?
Medical Instruments & Supplies giant West Pharmaceutical Services, Inc. (WST) is based in the USA and is one of the largest companies in the market. When comparing West Pharmaceutical Services, Inc. shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 50.71, there is a growth in quarterly earnings of 34.08%.
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.55%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.96% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
WST shares are owned by institutional investors to the tune of 95.96% at present.
